Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
A Randomised Comparison of Short and Protracted Neoadjuvant Hormonal Therapy Prior to Radiation Therapy of High Risk Localized Prostate Cancer
Sponsor: St. Luke's Hospital, Ireland
Listed as NCT00003734, this PHASE3 trial focuses on Prostate Cancer and remains ongoing. Sponsored by St. Luke's Hospital, Ireland, it has been updated 5 times since 1998, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Dec 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- St. Luke's Hospital, Ireland
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Belfast, United Kingdom
- • Cork, Ireland
- • Donnegal, Ireland
- • Dublin, Ireland
- • Galway, Ireland
- • Limerick, Ireland
- • Sligo, Ireland